Orthopedic Pioneer Lends Perspective on Industry Opportunities
Marshall Steele, M.D. shares insights on orthopedics and on how the COVID pandemic may change relationships and contracting strategies....
May 20, 2020,
Orthopedic Pioneer Lends Perspective on Industry Opportunities
Indago Seeks to Reduce O.R. Inefficiencies with ArthroFree Arthroscopic Camera System
The company has developed a number of fundamental technologies to eliminate the cables that are currently endemic to endoscopic procedures....
May 20, 2020,
What Does the Next Generation of Total Ankles Need?
Preoperative planning, surgical instrumentation and bony ingrowth are advancements that surgeon Alan Davis, M.D., says are a must for future...
May 20, 2020,
Medacta CEO Confident in Orthopedics’ Fundamentals
Mr. Francesco Siccardi opens up about market opportunities, headwinds and strategies for Medacta while dealing with the COVID-19 outbreak....
May 20, 2020,
Cerapedics Announces Results from Clinical Trial of i-FACTOR in Lumbar Fusion
Results show that elderly patients undergoing non-instrumented fusion achieve statistically significantly higher fusion rates with i-FACTOR vs. allograft....
May 19, 2020,
Orthopedics to Take Unprecedented Hit from COVID-19, Market Fundamentals Remain Strong
The underlying fundamentals of the orthopedic industry remain unchanged due to COVID-19. However, we should prepare for significant alterations in...
May 19, 2020,
NG Medical Launches BEE 3D Ti Cervical Interbody Cage
The BEE 3D Ti cage features a honeycomb structure designed to optimize bone ingrowth and fusion while reducing subsidence....
May 18, 2020,
Implanet to Divest Madison Total Knee Assets, Focus on Spine
The exclusive negotiations to sell the Madison total knee implant allow the company to focus on growing its spine business....
May 18, 2020,
Zebra Medical Vision Gains FDA Clearance for Spine Fracture AI Solution
Zebra-Med secured clearance for a product helping to identify more patients at risk of osteoporosis, as 70% of VCFs are...
May 18, 2020,
Bone Therapeutics Treats First Patients in Phase III Knee Osteoarthritis Study
The JTA-004 Phase III study is approved in five of seven territories. These are the first patients treated after resumption...
May 18, 2020,
Loading new posts...
No more posts
